FMC v. Natco: The Delhi High Court Ruling

FMC v. Natco

Recently, The High Court of Delhi delivered a judgment in FMC v. Natco, a case between FMC Corporation and others (“FMC group”) and Natco Pharma Limited (“Natco”).

The Dutch Court Refuses SPC for Durvalumab

SPC for Durvalumab

In a landmark decision concerning SPC for Durvalumab, the District Court of The Hague upheld the Dutch Intellectual Property Office’s (IPO) refusal to grant a Supplementary Protection Certificate (SPC) for AstraZeneca’s cancer immunotherapy drug Durvalumab, marketed as Imfinzi®. Durvalumab is an anti-PD-L1 antibody used in treating various cancers, and the refusal of SPC status has … Read more

IP Strategy Every Perfume Brand Needs: No. 3 is a Game-Changer

IP Strategy Every Perfume Brand Needs 1

The Indian perfume and attar market has been booming, especially after the rise of popular brands showcased on Shark Tank India Season 3. Among these brands, Adil Qadri has become a household name and even successfully secured funding from Sugar Cosmetics’ founder, Vineeta Singh. However, with fame comes challenges one of the biggest being counterfeit … Read more

Scooter in Design Patent is the Ultraviolette Tesseract? Detailed Comparison

Ultraviolette Tesseract

Electric mobility in India has rapidly evolved, and one name that consistently pushes design and innovation boundaries is Ultraviolette Automotive Private Limited. On Nov 14, 2025, The Indian Patent Office published new design patent filed by Ultraviolette Automotive Private Limited titled as scooter. Ultraviolette is known for its aviation-inspired engineering and futuristic EV philosophy, the … Read more

Is it Hyundai Next-Gen Venue’s Design Patent? Key Visual Comparisons Explained

Hyundai Next Gen Venue

Hyundai’s influence in the compact SUV segment has only grown stronger over the years. Now, a new design patent published in India on Nov. 14, 2025, reveals a bold and futuristic exterior styling direction. With the next-gen Hyundai Venue already generating significant buzz through spy shots, teasers, and early design comparisons, enthusiasts are naturally curious: … Read more

OLA Electric’s New Battery Electrode Composite

OLA Electrics New Battery

OLA Electric’s New Battery might just change the way we think about long-lasting, high-performance EVs and the secret lies in a tiny but powerful component called the “electrode.” If you have ever wondered why some electric vehicle batteries fade quickly while others stay strong, this thin internal layer plays a massive role. In a recent … Read more

Apple’s Next Move? Is It Magnetically Attachable Gaming Accessory?

Apples Next Move

Apple’s Next Move might just change the way we play mobile games. If you’ve ever tried tackling fast-paced titles on your phone or tablet, you know the struggle thumbs blocking the screen, touch controls that lack precision, and accessories that feel bulky or awkward.

Meta Platforms Files Petition to invalidate SitNet’s Social Network Patent

Meta Files Petition

Meta Platforms, Inc., the parent company of Facebook, filed a petition with the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) on November 10, 2025, seeking to invalidate all claims of SitNet’s U.S. Patent No. 12,256,463 B2. Basic Details of the Petition: Basic information of the Patent (463)? The 463 patent claims … Read more

Ultrahuman’s Next-Gen Wearables: Files Patent for Physiological Stress Monitoring System

Ultrahuman’s Next-Gen Wearables

If you have ever wondered why some days feel more stressful than others even when you sleep well? In the recent development there’s exciting news from the world of health tech, Ultrahuman’s Next-Gen Wearables: Files Patent for Physiological Stress Monitoring System, introducing a smart real-time monitoring technology that tracks stress by analyzing your body’s natural … Read more

Interim Injunction in the Empagliflozin “Jardiance” Patent Dispute

Interim Injunction in the Empagliflozin Jardiance Dispute

On Nov 5, 2025, the Patents Court handed down an important interim injunction decision in Dr Reddy’s Laboratories (UK) Ltd v Boehringer Ingelheim International GmbH, neutral citation EWHC 2834 (Pat). Michael Tappin KC, sitting as a Deputy Judge, granted interim relief restraining Dr Reddy’s from dealing in empagliflozin (the active in Jardiance) in the UK … Read more

We would love to hear from you! Get in touch with us for any queries, feedback, or collaboration opportunities.